Lowenberg b (69 résultats)

Ohlwd in Plastik eingebunden. 136 (v. 148)S. Mit 4 farbigen lithogr. Tafelillustr. - Im Falz geplatzt, Vorsatzbl. fl. u. m. kl. Randbeschädigungen, vereinzelt gering fl. Es Fehlen die letzten 12 Seiten! 467 gr.

12°. 86 Seiten. Mit 15 Abb. OBroschur. Miniaturbibliothek Nr. 156-157.

As new. Hard bound, illustrated, extensively referenced, x + Pp209. NEW in laminated boards. 445 grams.

146, 88 S. Blaue Original Leinwand mit schwarzgeprägtem verziertem Rückentitel, Deckel-Verzierung und goldgeprägtem Deckeltitel. Einband etwas berieben und bestoßen. Eigenvermerk auf fliegendem Vorsatz, papierbedingt gegilbt, sonst gut erhalten.

Etat : Very Good. Bon état. Sans date. Very Good.

Etat : New.

Halbleinen. Etat : Gut. C.S.B. Löwenberg - Hochmut kommt vor dem Fall - Ein schlesisches Städtebild aus der Zeit der Hussitenkriege HC mit farbig bedrucktem Einband - Carl Schaller-Verlag, Fürth i.B. - 146 Seiten Für die reifere deutsche Jugend von von Löwenberg mit seinen Farbendruckbildern Zustand: Gebräunt, ein Farbbild lose, Einband an den Kanten bestossen, Namenseintrag und Stempel im Vorsatz, Text sauber und in gutem Zustand! Size: 17 x 23 Cm. von Löwenberg (illustrateur). Buch.…

Etat : New. pp. 416.

Paperback. Etat : Brand New. 416 pages. 9.25x6.10x0.94 inches. In Stock.

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The objective of the treatment of acute leukemia involves the eradication of all neoplastic cells, including the last one. Ideally, treatment should be controlled by monitoring cell kill. If the last cells could be discovered and their biological properties be determined, the qualitative and quantitative effects of treatment should be directly evaluable. This should ultimately permit a calculated tumor cell reduction thereby avoiding overtreatment and excessive toxicity and thus providing a basis for individualized antileukemic treatment. In recent years several new developments have contributed to the selective discovery of minimal numbers of leukemic cells which are hidden among the normal cells in the marrow cavities. These methods are the first steps to the realization of the therapeutic goals indicated above. They include the production and ap plication of monoclonal antibodies against differentiation antigens on the cell sur face, the use of pulse cytophotometry - and cell sorter techniques, the employment of cytogenetics, the development of culture techniques for selective growth of precursor cells and several others. These methodologies offer prospects for refined diagnosis and, as far as the elimination of leukemic cells is concerned, the further development of autologous bone marrow transplantation. Eliminating tumor cells from autologous grafts requires the detailed knowledge of the cellular inter relationships within the neoplasm so that the neoplastic cells responsible for tumor propagation are specifically removed. Recognition and characterization of the clonogenic cells of the neoplasm should then lead to determining their sensitivity to the therapeutic agents which are clinically applied.…

Löwensohn, Fürth, (um 1900). 120 S. mit zahlr. Illustr. in Farbendruck, Halbleinen (etwas berieben und bestossen/vorderer Einbanddeckel gelockert/Name auf Vorsatz/Vorsatz gebräunt/gering fleckig)--- 348 Gramm.

Paperback. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Mit feinen Farbdruckbildern. Halbleinen 23x17 cm, stark beschädigt (Einband stark berieben, Rücken aufgeplatzt, Seiten braunfleckig fingerfleckig u. mit Randläsuren. Kritzelei auf Vorsatzblatt, Stempel auf S. 1. 146 S. Gewicht in Gramm: 500.

Etat : As New. Unread book in perfect condition.

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : New.

Etat : As New. Unread book in perfect condition.

Taschenbuch. Etat : Neu. Cytokines and Growth Factors in Blood Transfusion | Proceedings of the Twentyfirst International Symposium on Blood Transfusion, Groningen 1996, organized by the Red Cross Blood Bank Noord Nederland | C. Th. Smit Sibinga (u. a.) | Taschenbuch | xiv | Englisch | 2011 | Springer | EAN 9781461284352 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Etat : New. Proceedings of the Twenty-First International Symposium on Blood Transfusion, Groningen 1996, organized by the Red Cross Blood Bank Noord-Nederland Editor(s): Sibinga, C.Th.Smit; Das, P. C.; Lowenberg, B. Series: Developments in Hematology and Immunology. Num Pages: 206 pages, biography. BIC Classification: MFCC. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 14. Weight in Grams: 1090. . 1997. Hardback. . . . . …

Etat : New.

Gebunden. Etat : New. Proceedings of the Twenty-First International Symposium on Blood Transfusion, Groningen 1996, organized by the Red Cross Blood Bank Noord-Nederland Cytokines are cellular growth factors which also provide communication between cells and their mi.

Etat : New.

Etat : As New. Unread book in perfect condition.

Etat : New. pp. 224.

Paperback. Etat : Brand New. reprint edition. 216 pages. 9.44x6.31x0.51 inches. In Stock.

Etat : New. Proceedings of the Twenty-First International Symposium on Blood Transfusion, Groningen 1996, organized by the Red Cross Blood Bank Noord-Nederland Editor(s): Sibinga, C.Th.Smit; Das, P. C.; Lowenberg, B. Series: Developments in Hematology and Immunology. Num Pages: 206 pages, biography. BIC Classification: MFCC. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 14. Weight in Grams: 1090. . 1997. Hardback. . . . . Books ship from the US and Ireland. …

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Relapse of leukemia following successful remission-induction therapy remains a major obstacle in the treatment of patients with acute leukemia. Leukemia recurs most frequently in patients with acute myeloblastic leukemia (AML) and high risk acute lymphoblastic leukemia (ALL) following chemotherapy and less often in patients with low risk ALL and particularly in patient groups submitted to allogeneic marrow transplantation. ' It is likely that the great majority of these recurrences originate from residual leukemic cells that survive initial remission-induction chemotherapy. Today, several research groups throughout the world place emphasis on studies concerned with the detection and treatment of 'minimal residual disease' (MRD). These investigations are conducted with the common objective to tackle the remaining cells. 'Minimal Residual Disease in Acute Leukemia: 1986' summarizes the fast advancements in this area. Several disciplines are concerned with the analysis of leukemic cells. The perspectives of cytogenetic and molecular genetic approaches for applica tion in the detection of MRD are reviewed. In this respect, modern cyto genetics provide highly specific tumor markers. The resolution of cyto genetic methods can be particularly improved when combined with other techniques which select relevant subpopulations of cells. Characterization of oncogenes and gene rearrangements, including those of immunoglobulin and T-cell receptor genes, and the measurement of gene products, have been established. Techniques based on these approaches offer interesting tools for the detection of MRD. New possibilities of employing monoclonal anti bodies are also presented.…

Buch. Etat : Neu. Neuware - Cytokines are cellular growth factors which also provide communication between cells and their milieu. This clearly is an exciting area in modern medicine that will have significant impact on various facets of transfusion. Erythropoietin therapy stimulates red cell production while thrombopoietin seems to positively affect megakaryopoiesis and can be an added armamentarium for the thrombocytopenic patient. Using haematnopoietic growth factors, stem cells could be mobilized early to the peripheral blood for collection and subsequent transplantation into haemato-oncology patients instead of bone marrow transplantation. Using a cocktail of cytokines in cell culture, stem cells could be expanded and selected for therapy. Cytokines and growth factors can even be modified, which may lead to successful gene therapy in malignancies, including solid tumour vaccines. However, the presence of cytokines in certain blood products could have biological effects following transfusion, although its clinical relevance needs to be ascertained. There is much potential for the use of cytokines in the treatment of infections. Early diagnostic methods are now available to monitor their levels and relevance. It is likely that cytokines will increasingly play a role in therapy and could develop our fundamental knowledge about the development of T-cells. An ethical dilemma remains, however, regarding the use of cytokines in healthy donors for harvesting suitable specific cells. Longer clinical observation will be necessary to gather the necessary information. Cytokines and growth factors in blood transfusion was the theme of the 21st International Symposium in Blood Transfusion, where twenty clinicians and scientists, experts in their own fields, were invited to update the above information. Their findings are presented in four sections in this volume: Fundamental aspects - cytokines in development of T-cells, growth factors in haematopoiesis, growth factor receptors and signal transduction, cytokine response in platelet and whole blood transfusions. Function, production and diagnosis &endash; laboratory diagnostics of cytokines and growth factors, cytokines in blood components, cytokines and growth factors in cell expansions, cytokines for genetic modification towards gene therapy, progenitor cells from healthy donors. Application in clinical medicine &endash; clinical relevance of cytokines in transfusion products, cytokines and growth factors in solid tumours, gene therapy in malignancies, vaccine strategies inducing T-cell immunity against tumours, cytokines in the treatment of infections, thrombopoietin and megakaryopoiesis. Future potential use in transfusion medicine &endash; erythropoietin, immunotherapy, ethical aspects of the use of cytokines and growth factors in donors, potential of cytokines and growth factors in transfusion medicine.…

Etat : New. pp. 408.